c-LEcta is a company active in the industrial biotechnology field. We develop enzymes and production strains, which are used for the industrial production of drugs, nutrition and cosmetic products.

c-LEcta is a fully integrated industrial biotechnology company located in Leipzig, Germany. The company currently employs about 50 people and has established itself as leading player in the realization of high-value biotech products for regulated markets, either as in-house developments or in close cooperation with the industry. c-LEcta delivers cost-efficient and sustainable production processes which enable to open new and to better penetrate existing markets. c-LEcta was the first biotech company financed by the HTGF.


Dr. Marc Struhalla

CEO und Gründer

Thomas Pfaadt


Press releases

c-LEcta lays foundation for further growth and closes financing round

Closing of financing round with new investors Capricorn and bm|t brings growth capital and valuable access to international network Growth financing to take c-LEcta to a new level by upscaling food ingredients manufacturing to commercial production in a multi-billion-euro market New CFO Thomas Pfaadt to manage…

Info & Contact

Dr. Marc Struhalla
Thomas Pfaadt


Perlickstraße 5
04103 Leipzig

In portfolio

19. Jan 2006